SRI-011381 (C381) is a novel agonist of the TGF-beta signaling pathway for treatment of Alzheimer’s disease.C381 physically targets the lysosome, promotes lysosomal acidification, increases breakdown of lysosomal cargo, and improves lysosome resilience to damage.